Mr. John Fowler reports

SUPREME STRENGTHENS MANAGEMENT TEAM WITH APPOINTMENT OF NEW DIRECTOR

Supreme Pharmaceuticals Inc. has appointed Navdeep Dhaliwal to the company's board of directors. Mr. Dhaliwal's primary focus will be the development of Supreme's go-to-market strategy, in addition to corporate development and capital markets initiatives. "This is an exciting time for Supreme. I am looking forward to working with Supreme's leadership team to leverage my experiences growing businesses, particularly in the on-line space," said Mr. Dhaliwal.

Mr. Dhaliwal is a chartered accountant and currently serves as the principal of NLX Capital Corp., a Toronto-based corporate development firm focused primarily on technology and renewable energy. Mr. Dhaliwal was recently retained by a Toronto software company where he successfully expanded the company's business into South East Asia, where Mr. Dhaliwal has extensive business experience.

Mr. Dhaliwal has been involved in the Canadian medical marijuana space for two years prior to joining Supreme and states, "I believe there is a strong positive outlook for the Canadian marijuana industry, particularly amongst producers harnessing the power of sunlight to reduce costs and improve sustainability."

Concurrent with Mr. Dhaliwal's appointment, the Supreme's board of directors accepted the resignation of Allan Levien, a long-serving director of the company. Supreme thanks Mr. Levien for his years of dedicated service and wishes him the best in all of his present and future endeavours. Supreme's president, John Fowler, commented: "Mr. Levien was instrumental in transitioning Supreme into the cannabis industry, and I am thankful for his vision. I am also very excited to welcome Mr. Dhaliwal to Supreme's board of directors as he will play an integral role for us as we plan to hit the ground running in the next phase of our business development."

We seek Safe Harbor.